CRDL
Cardiol Therapeutics
CRDL
CRDL
46 hedge funds and large institutions have $7.65M invested in Cardiol Therapeutics in 2025 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
67% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 12
Holders
46
Holding in Top 10
–
Calls
$73K
Puts
–
Top Buyers
| 1 | +$582K | |
| 2 | +$561K | |
| 3 | +$496K | |
| 4 |
Goldman Sachs
New York
|
+$283K |
| 5 |
Two Sigma Investments
New York
|
+$249K |
Top Sellers
| 1 | -$680K | |
| 2 | -$461K | |
| 3 | -$321K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$280K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
-$144K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WANY
51
Wealthspire Advisors (New York)
New York
| – |
|
|||
52
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| – |
|
|||
53
Raymond James Financial
St Petersburg,
Florida
| – |
|